Strides Pharma Science Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sales

2,139.42

2,153.26

1,854.50

1,979.00

1,857.57

Operating profit

262.44

255.28

98.48

76.63

187.32

Interest

145.91

167.93

138.68

74.24

65.34

Gross profit

162.72

159.65

43.86

125.87

210.98

EPS (Rs)

313.16

7.13

0.52

20.07

8.72

Other income

46.19

72.31

84.07

123.49

89.00

Stock adjustment

-27.20

4.62

21.04

114.26

-117.53

Raw material

1,048.11

1,072.63

1,020.10

935.42

1,050.10

Power and fuel

-

-

-

-

-

Employee expenses

377.59

335.21

267.01

272.09

272.72

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

478.49

485.53

447.87

580.60

464.96

Provisions made

-

-

-

-

-

Depreciation

84.61

84.67

93.62

104.37

99.34

Taxation

18.93

4.13

-69.44

-158.68

33.40

Net profit / loss

2,886.21

65.49

4.68

180.19

78.24

Extra ordinary item

2,827.03

-5.37

-15.00

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

92.16

91.90

90.30

89.79

89.68

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

12.27

11.86

5.31

3.87

10.08

GPM (%)

7.44

7.17

2.26

5.99

10.84

NPM (%)

132.06

2.94

0.24

8.57

4.02